A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle‐cell disease
Pediatric Blood & Cancer2014Vol. 61(6), pp. 1068–1073
Citations Over TimeTop 10% of 2014 papers
Abstract
This study demonstrates electronic DOT is feasible, acceptable, and can achieve high HU adherence. Further study is needed to confirm that electronic DOT can improve HU adherence and impact clinical outcomes in children with SCD.
Related Papers
- → A Controlled Comparison of Directly Observed Therapy vs Self-administered Therapy for Active Tuberculosis in the Urban United States(1998)33 cited
- DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.(2005)
- → DOES UNIVERSAL DOT REALLY MAKES A DIFFERENCE IN TUBERCULOSIS TREATMENT?(2005)1 cited
- → PDB14 USE OF 8-ITEM MORISKY MEDICATION ADHERENCE SCALE FOR THE ASSESSMENT OF MEDICATION ADHERENCE IN TYPE 2 DIABETES MELLITUS(2010)
- → A Prospective Descriptive Study to Assess the Medication Adherence Using Morisky Medication Adherence Scale in Type II Diabetes Mellitus Patients(2023)